Zacks.com on MSN1d
Catalent Stock Flat Following the Sell Agreement With ArdenaCTLT announces an agreement to sell its oral solids development and manufacturing facility in Somerset to Ardena.
Somerset facility State-of-the art facility for clinical and commercial manufacturing of oral dosage forms. Ghent, Belgium, ...
Awaiting a potential acquisition by Novo Holdings, Catalent is giving its contract manufacturing compatriot a boost as Ardena ...
Ardena inks agreement to acquire Catalent’s state-of-the-art facility in Somerset, New Jersey: Ghent, Belgium Tuesday, October 15, 2024, 16:00 Hrs [IST] Ardena, a specialist pha ...
The FDA-approved Somerset facility employs approximately 200 skilled scientists and technicians and is a Center of Excellence for advanced delivery of oral dosage forms, complementing Ardena's ...
Ghent, Belgium, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Ardena, a specialist pharmaceutical Contract Development and Manufacturing Organisation (CDMO) with GMP facilities in Belgium, Spain, the ...
Catalent entered into a definitive agreement to sell its oral solids development and small-scale manufacturing facility in ...
(MENAFN- GlobeNewsWire - Nasdaq) Ghent, Belgium, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Ardena, a specialist Pharmaceutical Contract Development and manufacturing Organisation (CDMO) with GMP ...
Catalent, Inc. (CTLT), a provider of advanced delivery technologies and development solutions for drugs, biologics, and consumer ...
At CPHI Milan 2024, Ardena will showcase its latest advancements in drug development and manufacturing, including the launch ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback